Table 1 Demographic, clinical, and inflammatory characteristics of patients with asthma

N

232

Age, years

 ≤ 20

8 (3.4%)

 21–40

39 (16.8%)

 41–60

129 (55.6%)

 61–80

56 (24.1%)

Sex (M/F)

109/123

Height, cm

166 ± 7.9

Weight, kg

65 ± 11.2

Never smoker, N (%)

133 (57.3%)

Ex-smokers (n) (pack-years)

50 (16 (5.2, 16.0))

Current smokers (n) (pack-years)

49 (22 (13.0, 37.3))

Diagnosis age (y)

45 ± 15

Total controlled, N (%)

70 (30.2%)

Partial controlled, N (%)

60 (25.9%)

Severe asthma, N (%)

89 (38.4%)

Atopy (Y/N)

37/80

ACO, N (%)

118 (50.8%)

Triggering factors (Y/N)

200/32

Seasons, N (%)

114 (49.1%)

Exercise, N (%)

101 (43.5%)

URTI, N (%)

141 (60.7%)

Work, N (%)

20 (8.6%)

Gastroesophageal reflux, N (%)

14 (6.0%)

Pets, N (%)

11 (4.7%)

Food, N (%)

20 (8.6%)

Aspirin, N (%)

6 (2.6%)

Fumes, N (%)

50 (21.6%)

Rhinitis, N (%)

78 (33.6%)

Post-FEV1/FVC, %

67.9 ± 13.0

Post-FEV1% predicted

84.8 (63.9, 97.6)

FeNO (ppd)

40.9 (23.1, 77.8)

Application of ICS/(ICS + LABA) in the past year (Y/N)

112/120

 ≤ 3 month, N (%)

39 (16.8%)

 3–6 month, N (%)

21 (9.1%)

 > 6 month, N (%)

52 (22.4%)